Showing 51 - 60 of 1032
Findings suggests examining brain differences can provide more targeted treatments for neurodiverse kids, youth
Read More
We are pleased to welcome Dr. Allyson Berent, Chief Science Officer; Foundation for Angelman Syndrome Therapeutics (FAST); Chief Development Officer AS2Bio; Co-Director Angelman Syndrome Biomarkers And Outcome Measures Consortium as our speaker for September.
Read More
Government of Canada invests over $20M to launch Pediatric Rare Disease Clinical Trials and Treatment Network
Read More
Lili Senman, M.A.Lili works as Research Coordinator at the Autism Research Centre at Holland Bloorview Kids Rehabilitation Centre. Lili i...
Read More
Dr. Krissy Doyle-Thomas, researcher and manager of research operations, Holland Bloorview's research instituteHolland Bloorview's researc...
Read More
Dr. Azadeh Kushki, a senior scientist at the BRI and an associate professor at the University of Toronto’s Institute of Biomedical Engineering, has been named CRC in Neurodiversity and Personalized Health.
Read More
A team of scientists at Holland Bloorview, CAMH and SickKids have found similar changes in white matter in the brains of children with au...
Read More
Holland Bloorview and SickKids have received $2.5 million from Brain Canada to conduct a five-year trial of new autism medicines in child...
Read More
An event hosted by The Conference Board of Canada will occur on March 2, 2016 in Toronto, Ontario. Bloorview Research Institute Senior Cl...
Read More
A comprehensive piece on what autism spectrum disorder is and understanding its many forms.
Read More
